weaning off glp-1 GLP-1s: How to Taper Off Your Stopping GLP-1s Safely: What to
Description
Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials
2024;7:e462
GLP-1 molecules are large peptides, far bigger than the tiny, fat loving molecules that can slip through skin passively
Access Lifestyle Approaches for Managing Type 2 Diabetes Which Option Should I Choose? This new toolkit is available on the Weight Management Dietetic Practice Group website and aims to assist RDs who counsel adults with type 2 diabetes to integrate shared decision making with counseling
Acta 73 HolstJ
When Staying Longer At A Dose Works Better Than Escalating Its a common assumption that increasing the dose is the best way to break a plateau
